Devyser Diagnostics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 110

Employees

  • Stock Symbol
  • DVYSR

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $6.54
  • (As of Friday Closing)

Devyser Diagnostics General Information

Description

Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Contact Information

Website
www.devyser.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Branningevagen 12
  • 120 54 Arsta
  • Sweden
+46 08-562
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Stock Exchange
STO
Corporate Office
  • Branningevagen 12
  • 120 54 Arsta
  • Sweden
+46 08-562

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Devyser Diagnostics Stock Performance

As of 13-Nov-2026, Devyser Diagnostics’s stock price is $6.54. Its current market cap is $110M with 16.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.54 $6.52 $4.86 - $12.96 $110M 16.9M 18.7K $0.16

Devyser Diagnostics Financials Summary

As of 30-Sep-2026, Devyser Diagnostics has a trailing 12-month revenue of $27M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 82,312 203,404 167,742 106,681
Revenue 27,000 25,497 20,509 15,928
EBITDA 6,151 2,707 (2,893) (4,281)
Net Income 2,703 (855) (5,815) (5,043)
Total Assets 49,519 51,044 42,942 51,041
Total Debt 4,402 5,640 5,356 7,485
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Devyser Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Devyser Diagnostics‘s full profile, request access.

Request a free trial

Devyser Diagnostics Patents

Devyser Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3408408-A1 Selective amplification of desired nucleic acid regions in a target sequence Active 27-Jan-2016
US-10246740-B2 Selective amplification of desired nucleic acid regions in a target sequence Active 27-Jan-2016
US-20180371528-A1 Selective amplification of desired nucleic acid regions in a target sequence Active 27-Jan-2016
WO-2017129756-A1 Selective amplification of desired nucleic acid regions in a target sequence Inactive 27-Jan-2016
EP-3408408-B1 Selective amplification of desired nucleic acid regions in a target sequence. Active 27-Jan-2016 C12Q1/686
To view Devyser Diagnostics’s complete patent history, request access »

Devyser Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Devyser Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Devyser Diagnostics‘s full profile, request access.

Request a free trial

Devyser Diagnostics Investments & Acquisitions (3)

Devyser Diagnostics’s most recent deal was a Merger/Acquisition with CyberGene for . The deal was made on 01-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CyberGene 01-Apr-2026 Merger/Acquisition Diagnostic Equipment
SmartSeq 04-Feb-2022 Merger/Acquisition Decision/Risk Analysis
SmartSeq 01-Dec-2018 Secondary Transaction - Private Decision/Risk Analysis
To view Devyser Diagnostics’s complete investments and acquisitions history, request access »

Devyser Diagnostics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Devyser Diagnostics’s complete esg history, request access »

Devyser Diagnostics Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
SmartSeq Alessandria, Italy 2013
CyberGene Solna, Sweden 1995

Devyser Diagnostics FAQs

  • When was Devyser Diagnostics founded?

    Devyser Diagnostics was founded in 2004.

  • Where is Devyser Diagnostics headquartered?

    Devyser Diagnostics is headquartered in Arsta, Sweden.

  • What is the size of Devyser Diagnostics?

    Devyser Diagnostics has 110 total employees.

  • What industry is Devyser Diagnostics in?

    Devyser Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Devyser Diagnostics a private or public company?

    Devyser Diagnostics is a Public company.

  • What is Devyser Diagnostics’s stock symbol?

    The ticker symbol for Devyser Diagnostics is DVYSR.

  • What is the current stock price of Devyser Diagnostics?

    As of 13-Nov-2026 the stock price of Devyser Diagnostics is $6.54.

  • What is the current market cap of Devyser Diagnostics?

    The current market capitalization of Devyser Diagnostics is $110M.

  • What is Devyser Diagnostics’s current revenue?

    The trailing twelve month revenue for Devyser Diagnostics is $27M.

  • What is Devyser Diagnostics’s annual earnings per share (EPS)?

    Devyser Diagnostics’s EPS for 12 months was $0.16.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process